Literature DB >> 24901557

The cancer-virus cures.

David Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24901557     DOI： 10.1038/nm0614-571

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  Epstein-Barr virus: an important vaccine target for cancer prevention.

Authors:  Jeffrey I Cohen; Anthony S Fauci; Harold Varmus; Gary J Nabel
Journal:  Sci Transl Med       Date:  2011-11-02       Impact factor: 17.956

3.  Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients.

Authors:  Edwin P Hui; Graham S Taylor; Hui Jia; Brigette B Y Ma; Stephen L Chan; Rosalie Ho; Wai-Lap Wong; Steven Wilson; Benjamin F Johnson; Ceri Edwards; Deborah D Stocken; Alan B Rickinson; Neil M Steven; Anthony T C Chan
Journal:  Cancer Res       Date:  2013-01-24       Impact factor: 12.701

4.  Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.

Authors:  Catherine M Bollard; Stephen Gottschalk; Vicky Torrano; Oumar Diouf; Stephanie Ku; Yasmin Hazrat; George Carrum; Carlos Ramos; Luis Fayad; Elizabeth J Shpall; Barbara Pro; Hao Liu; Meng-Fen Wu; Daniel Lee; Andrea M Sheehan; Youli Zu; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney
Journal:  J Clin Oncol       Date:  2013-12-16       Impact factor: 44.544

5.  Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.

Authors:  Etienne M Sokal; Karel Hoppenbrouwers; Corinne Vandermeulen; Michel Moutschen; Philippe Léonard; Andre Moreels; Michèle Haumont; Alex Bollen; Françoise Smets; Martine Denis
Journal:  J Infect Dis       Date:  2007-12-15       Impact factor: 5.226

Review 6.  Biological agents.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2012
  6 in total
  9 in total

1.  Cancer prevention and control: alarming challenges in China.

Authors:  Ann M Bode; Zigang Dong; Hongyang Wang
Journal:  Natl Sci Rev       Date:  2015-08-29       Impact factor: 17.275

2.  Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells.

Authors:  Junping Hong; Dongmei Wei; Ling Zhong; Qian Wu; Kaiyun Chen; Wanlin Zhang; Yanbo Yang; Junyu Chen; Ningshao Xia; Xiao Zhang; Yixin Chen
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

Review 3.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

4.  Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.

Authors:  Longmei Cai; Jinbang Li; Xiaona Zhang; Yaoyong Lu; Jianguo Wang; Xiaoming Lyu; Yuxiang Chen; Jinkun Liu; Hongbing Cai; Ying Wang; Xin Li
Journal:  Oncotarget       Date:  2015-04-10

5.  EBV based cancer prevention and therapy in nasopharyngeal carcinoma.

Authors:  Ya Cao
Journal:  NPJ Precis Oncol       Date:  2017-05-15

6.  LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling.

Authors:  Zhibao Zhang; Xuehui Yu; Zhuan Zhou; Bo Li; Jinwu Peng; Xia Wu; Xiangjian Luo; Lifang Yang
Journal:  Cancer Med       Date:  2019-08-22       Impact factor: 4.452

7.  EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway.

Authors:  Xiaohan Zhou; Jialing Zheng; Ying Tang; Yanling Lin; Lingzhi Wang; Ye Li; Chengdong Liu; Dehua Wu; Longmei Cai
Journal:  Biosci Rep       Date:  2019-09-13       Impact factor: 3.840

Review 8.  The Hippo Pathway and Viral Infections.

Authors:  Zhilong Wang; Wanhang Lu; Yiling Zhang; Feng Zou; Zhigang Jin; Tiejun Zhao
Journal:  Front Microbiol       Date:  2020-01-23       Impact factor: 5.640

9.  Positive regulation of TAZ expression by EBV-LMP1 contributes to cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma.

Authors:  Jiang He; Feiyu Tang; Liyu Liu; Lin Chen; Jiang Li; Danming Ou; Lu Zhang; Zhi Li; Deyun Feng; Wenzheng Li; Lun-Quan Sun
Journal:  Oncotarget       Date:  2016-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.